CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $543.25 | $326K | 328,483 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −840 | $544.05 | $457K | 327,643 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −920 | $545.13 | $502K | 326,723 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $546.23 | $197K | 326,363 |
| 2026-09-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 328,410 | ||
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $472.05 | $189K | 333,543 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −449 | $472.97 | $212K | 333,094 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $473.86 | $38K | 333,014 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −552 | $475.12 | $262K | 332,462 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,395 | $476.10 | $664K | 331,067 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,135 | $477.09 | $1.0M | 328,932 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,309 | $478.10 | $1.1M | 326,623 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,200 | $479.07 | $575K | 325,423 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $479.59 | $77K | 325,263 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $481.22 | $241K | 324,763 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $482.28 | $58K | 324,643 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $486.77 | $97K | 324,443 |
| 2026-09-29 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 337,910 | ||
| 2026-09-28 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
Page 30 of 121 · 2,404 trades